We are pleased to announce that Maria Engström has been appointed Chief Financial Officer.
Maria Engström brings over 25 years of experience across senior business and finance functions and most recently serving as CFO of Cinclus Pharma and previously at Sedana Medical. She has held a range of financial roles within technology- and research-intensive companies, including Medivir, Bristol Myers Squibb and Ericsson.
“We are delighted to welcome Maria as the new CFO of Silex. She brings financial expertise and has experience in scaling and strengthening financial functions in growing companies. With her background in senior leadership roles at research-intensive companies, her strategic insights and experience from listed companies will be instrumental as we continue to execute our priorities and reinforce our market-leading position in the MEMS industry”, says Edvard Kälvesten, CEO of Silex.
“I am very excited to be joining Silex as their new CFO. As the world’s leading MEMS foundry, Silex has strong technical expertise and is widely recognized as a frontrunner in shaping MEMS technology globally. At the same time, the market is growing and the opportunities are great. I look forward to working closely with the management team to drive Silex’s financial strategy and create long-term growth”, says Maria Engström.